(2009) were the first to report an association between CMT and variants in BRCA1 and BRCA2. They studied ESSs from Sweden, where 36% of the population is affected, by carrying out a case–control study involving 212 CMT cases and 143 CMT‐unaffected controls. This evidence concerns the gene BRCA2 and Charcot-Marie-Tooth disease.